PDS Biotechnology Corp Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
PDS Biotechnology Corp quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • PDS Biotechnology Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2023 was $239K, a 18.8% decline from 2022.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2022 was $295K, a 72.7% increase from 2021.
  • PDS Biotechnology Corp annual Operating Lease, Payments for 2021 was $171K, a 74.1% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $239K -$55.5K -18.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $295K +$124K +72.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $171K +$72.7K +74.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $98.1K +$98.1K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.